Mode
Text Size
Log in / Sign up
N/A Completed N=72

PREDICT: A PBRN Feasibility Study on COVID-19 Screening in Dental Practice

COVID-19 Infection
Source: ClinicalTrials.gov NCT05123742 ↗
Enrolled (actual)
72
Serious AEs
0.0%
Results posted
Oct 2023
Primary outcomePrimary: Perception of Safety — 60; 74; 51; 52.5 score on a scale

Summary

The study team will conduct a feasibility study to develop and test out procedures for improved triage and COVID-19 testing in dental practices to increase safety and perceptions of the safety of Dental Health Care Workers (DHCW) and their patients. DHCWs in offices with Practice-Based Regional Network (PBRN) members and their patients will be recruited to participate in one of two protocols. The first, point-of-care (POC), will test out procedures for point-of-care SARS-CoV-2 antigen testing in the dental office along with enhanced triage using pulse oximeters. The second, laboratory (LAB), will test out procedures for a saliva-based laboratory SARS-CoV-2 viral test along with enhanced triage. The feasibility of implementing COVID-related testing and enhanced triage procedures in the dental setting will provide preliminary data to inform a larger network-wide study grant application.

Outcome Measures

OutcomeResultp-value
PRIMARY
Perception of Safety
60; 74; 51; 52.5; 95; 82
SECONDARY
Specimen Preference
1; 2; 3; 2; 2; 2
SECONDARY
Testing Protocol Preference
2; 1; 2; 1; 1; 3

Eligibility Criteria

Inclusion Criteria

A Dental Health Care Worker must meet all of the following criteria to be eligible to participate in the study:

  • Be 18 years or older
  • Be a National Dental PBRN member dentist or work in a dental office with a National Dental PBRN member dentist who consents to study participation
  • Be able to understand the informed consent.
  • Provide signed and dated informed consent form
  • Be able to understand all instructions for data collection instruments
  • Be willing and able to comply with all study procedures, including COVID-19 testing, and be available for the duration of the study

A Patient must meet all of the following criteria to be eligible to participate in the study:

  • Be 18 years or older
  • Be able to understand the informed consent.
  • Have a computer or electronic tablet with internet access
  • Able to complete consent and questionnaire on a computer or electronic tablet
  • Provide signed and dated informed consent form
  • Be able to understand all instructions for data collection instruments
  • Be willing and able to comply with all study procedures, including having a COVID-19 test performed

Exclusion Criteria

  • Children less than 18 years will not be able to participate.
  • Participants would be excluded if they participated in the feasibility study previously conducted at Rutgers University.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT05123742). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search